Innoviva Inc (INVA)
15.58
+0.30
(+1.96%)
USD |
NASDAQ |
May 10, 16:00
15.58
0.00 (0.00%)
After-Hours: 20:00
Innoviva Market Cap: 973.20M for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 954.47M |
| May 08, 2024 | 971.64M |
| May 07, 2024 | 969.77M |
| May 06, 2024 | 964.77M |
| May 03, 2024 | 949.16M |
| May 02, 2024 | 959.78M |
| May 01, 2024 | 951.03M |
| April 30, 2024 | 943.54M |
| April 29, 2024 | 971.54M |
| April 26, 2024 | 954.03M |
| April 25, 2024 | 937.15M |
| April 24, 2024 | 947.78M |
| April 23, 2024 | 948.41M |
| April 22, 2024 | 933.40M |
| April 19, 2024 | 934.65M |
| April 18, 2024 | 918.40M |
| April 17, 2024 | 909.30M |
| April 16, 2024 | 908.67M |
| April 15, 2024 | 904.28M |
| April 12, 2024 | 918.72M |
| April 11, 2024 | 923.74M |
| April 10, 2024 | 916.84M |
| April 09, 2024 | 924.37M |
| April 08, 2024 | 925.00M |
| April 05, 2024 | 920.60M |
| Date | Value |
|---|---|
| April 04, 2024 | 920.60M |
| April 03, 2024 | 930.02M |
| April 02, 2024 | 929.40M |
| April 01, 2024 | 955.14M |
| March 28, 2024 | 963.58M |
| March 27, 2024 | 966.75M |
| March 26, 2024 | 947.14M |
| March 25, 2024 | 954.10M |
| March 22, 2024 | 954.10M |
| March 21, 2024 | 947.78M |
| March 20, 2024 | 935.13M |
| March 19, 2024 | 925.02M |
| March 18, 2024 | 920.59M |
| March 15, 2024 | 939.56M |
| March 14, 2024 | 930.71M |
| March 13, 2024 | 932.60M |
| March 12, 2024 | 937.03M |
| March 11, 2024 | 935.13M |
| March 08, 2024 | 938.29M |
| March 07, 2024 | 953.47M |
| March 06, 2024 | 959.79M |
| March 05, 2024 | 940.82M |
| March 04, 2024 | 964.85M |
| March 01, 2024 | 963.58M |
| February 29, 2024 | 966.11M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
730.99M
Minimum
Mar 09 2023
1.546B
Maximum
Jun 22 2020
1.098B
Average
1.083B
Median
Dec 08 2020
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 2.420M |
| Palatin Technologies Inc | 36.63M |
| iBio Inc | 6.516M |
| Theriva Biologics Inc | 6.002M |
| Oragenics Inc | 8.245M |
Market Cap Related Metrics
| PE Ratio | 7.020 |
| PS Ratio | 4.016 |
| Price to Book Value | 1.383 |
| Price to Free Cash Flow | 8.210 |
| Price | 15.58 |
| Earnings Yield | 14.24% |
| Operating PE Ratio | 11.40 |
| Normalized PE Ratio | 6.991 |